Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 153
Filtrar
Mais filtros

Tipo de documento
Intervalo de ano de publicação
1.
J Antimicrob Chemother ; 72(2): 372-375, 2017 02.
Artigo em Inglês | MEDLINE | ID: mdl-27798212

RESUMO

BACKGROUND: MRSA is a therapeutic concern worldwide, and a major agent of community-acquired skin and soft tissue infections (CA-SSTIs). While the US epidemiology of MRSA in CA-SSTIs is well described and reports the high prevalence of the USA300 clone, data on the European situation are lacking. OBJECTIVES: To determine the prevalence and clonal characteristics of MRSA in CA-SSTIs in seven European emergency departments. PATIENTS AND METHODS: From April to June 2015, patients presenting to the tertiary hospital emergency department with a Staphylococcus aureus CA-SSTI were prospectively enrolled. S. aureus isolates were characterized by antimicrobial susceptibility testing, detection of Panton-Valentine leucocidin encoding genes and spa-typing, MLST and/or DNA microarray. RESULTS: Two-hundred and five cases of S. aureus-associated CA-SSTIs were included, comprising folliculitis, furuncles, abscesses, paronychia, impetigo, carbuncles and cellulitis. Of the 205 cases, we report an MRSA prevalence rate of 15.1%, with a north (0%) to south (29%) increasing gradient. Fifty-one isolates were Panton-Valentine leucocidin-positive (24.9%), whether MSSA or MRSA, with a heterogeneous distribution between countries. Clonal distribution of MSSA and MRSA showed high diversity, with no predominant circulating clone and no archetypical USA300 CA-MRSA clone. CONCLUSIONS: This original prospective multicentre study highlights stark differences in European MRSA epidemiology compared with the USA, and that the USA300 CA-MRSA clone is not predominant among community-infected patients in Europe.


Assuntos
Infecções Comunitárias Adquiridas/epidemiologia , Serviço Hospitalar de Emergência , Staphylococcus aureus Resistente à Meticilina/isolamento & purificação , Infecções dos Tecidos Moles/epidemiologia , Infecções Estafilocócicas/epidemiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Toxinas Bacterianas/genética , Criança , Pré-Escolar , Infecções Comunitárias Adquiridas/microbiologia , Europa (Continente)/epidemiologia , Exotoxinas/genética , Feminino , Genótipo , Humanos , Lactente , Leucocidinas/genética , Masculino , Staphylococcus aureus Resistente à Meticilina/classificação , Staphylococcus aureus Resistente à Meticilina/efeitos dos fármacos , Staphylococcus aureus Resistente à Meticilina/genética , Análise em Microsséries , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Epidemiologia Molecular , Tipagem de Sequências Multilocus , Análise de Sequência com Séries de Oligonucleotídeos , Prevalência , Estudos Prospectivos , Infecções dos Tecidos Moles/microbiologia , Infecções Estafilocócicas/microbiologia , Proteína Estafilocócica A/genética , Centros de Atenção Terciária , Adulto Jovem
2.
Mar Pollut Bull ; 201: 116191, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-38428048

RESUMO

Management of plastic litter in Marine Protected Areas (MPAs) is expensive but crucial to avoid harms to critical environments. In the present work, an open-source numerical modelling chain is proposed to estimate the seasonal pathways and fates of macro-plastics, and hence support the effective planning and implementation of sea and beach cleaning operations. The proposed approach is applied to the nearshore region that includes the MPA of Capo Milazzo (Italy). A sensitivity analysis on the influence of tides, wind, waves and river floods over the year indicates that seasonality only slightly affects the location and extension of the macro-plastic accumulation zones, and that beach cleaning operations should be performed in autumn. Instead, the influence of rivers on plastic litter distribution is crucial for the optimal planning of cleaning interventions in the coastal area.


Assuntos
Monitoramento Ambiental , Plásticos , Plásticos/análise , Estações do Ano , Vento , Rios , Resíduos/análise , Mar Mediterrâneo
3.
J Digit Imaging ; 21(1): 27-36, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17333413

RESUMO

In this paper, a fast, slice-by-slice, nonrigid registration algorithm of dynamic magnetic resonance breast images is presented. The method is based on a multiresolution motion estimation of the breast using complex discrete wavelet transform (CDWT): the pyramid of oriented complex subimages is used to implement a hierarchical phase-matching-based motion estimation algorithm. The resulting motion estimate is nonrigid and pixel-independent. To assess the method performance, we computed the correlation coefficient and the normalized mutual information between pre- and postcontrast images with and without realignment. The indices increased after using our approach and the improvement was superior to rigid or affine registration. A set of clinical scores was also evaluated. The clinical validation demonstrated an increased readability in the subtraction images. In particular, CDWT registration allowed a best definition of breast and lesion borders and greater detail detectability.


Assuntos
Algoritmos , Neoplasias da Mama/diagnóstico , Meios de Contraste , Processamento de Imagem Assistida por Computador , Imageamento por Ressonância Magnética , Neoplasias da Mama/diagnóstico por imagem , Feminino , Humanos , Processamento de Imagem Assistida por Computador/métodos , Imageamento por Ressonância Magnética/métodos , Radiografia
4.
Fitoterapia ; 78(2): 159-61, 2007 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17161920

RESUMO

The antifungal activity of methanolic extract and alkaloidal fraction of Berberis aetnensis against Candida species was investigated. The crude extract was active against Candida species, this activity being higher than that of the alkaloidal fraction and berberine.


Assuntos
Antifúngicos/farmacologia , Berberis , Candida/efeitos dos fármacos , Fitoterapia , Extratos Vegetais/farmacologia , Antifúngicos/administração & dosagem , Antifúngicos/uso terapêutico , Candida/classificação , Humanos , Testes de Sensibilidade Microbiana , Extratos Vegetais/administração & dosagem , Extratos Vegetais/uso terapêutico , Raízes de Plantas
5.
J Chemother ; 18(2): 164-71, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16736885

RESUMO

Propolis is produced by bees and is reported to have several pharmaceutical properties. Its antibacterial activity against strains causing upper respiratory tract infections is particularly important: propolis might be used as a therapeutic agent to prevent the bacterial infections that sometimes overlap viral infections. In this study the in vitro activity of both an alcoholic solution and a hydroglyceric extract of propolis, as well as its active principles, was tested against bacteria responsible for respiratory infections (Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis and Streptococcus pyogenes). We also evaluated the in vitro activity of a combination of propolis and its active principles and some beta-lactams, macrolides and fluoroquinolones. Our results, though not demonstrating a clearly synergistic activity between antibiotics and propolis and its constituents, show the possibility of using natural preparations, due to their antimicrobial and anti-inflammatory properties, to enhance antibacterial therapy.


Assuntos
Anti-Infecciosos/farmacologia , Bactérias/efeitos dos fármacos , Fluoroquinolonas/farmacologia , Macrolídeos/farmacologia , Própole/farmacologia , Infecções Respiratórias/microbiologia , beta-Lactamas/farmacologia , Bactérias/isolamento & purificação , Quimioterapia Combinada , Haemophilus influenzae/efeitos dos fármacos , Humanos , Testes de Sensibilidade Microbiana , Moraxella catarrhalis/efeitos dos fármacos , Infecções Respiratórias/tratamento farmacológico , Streptococcus pneumoniae/efeitos dos fármacos
6.
J Clin Oncol ; 4(1): 35-40, 1986 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-3941332

RESUMO

Sixty-two consecutive patients with clinical stage I nonseminomatous testicular cancer were entered into a prospective study to receive no treatment after orchiectomy until clinical evidence of recurrent disease. Of 59 evaluable cases, 41 (69.5%) remained continuously disease free for a median duration of 30 months (range, 18 to 46 months), and evidence of metastatic disease developed in 18 patients (30.5%) from 2 to 36 months after orchiectomy. The median disease-free interval for relapsing patients was 6 months. Retroperitoneal metastases developed in ten patients; seven patients had pulmonary metastases, and one patient had progressive elevation of the serum alpha-fetoprotein level. Relapses were significantly more frequent in patients with either embryonal carcinoma, infiltrating testicular cancer (pT greater than 1), peritumoral vascular invasion, or in those who underwent transscrotal biopsy. One patient with relapse refused salvage therapy and died. The remaining 17 patients have been rendered disease free with cisplatin combination chemotherapy and/or surgery. However, two patients showed further recurrence, with one in the lung and the other one also in the retroperitoneal nodes. In our opinion, surveillance following orchiectomy will provide useful information in clinical stage I nonseminomatous testicular cancer, but it is a difficult study. For the time being, it should be restricted to specialized centers only. In the meanwhile, retroperitoneal lymphadenectomy remains the standard treatment.


Assuntos
Orquiectomia , Neoplasias Testiculares/cirurgia , Adolescente , Adulto , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Metástase Neoplásica , Estadiamento de Neoplasias , Prognóstico , Risco , Neoplasias Testiculares/patologia
7.
J Clin Oncol ; 5(1): 27-37, 1987 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-2433409

RESUMO

In an attempt to reduce some of the delayed sequelae associated with combined modality therapy in Hodgkin's disease, we randomly tested stages IIB, IIIA, and IIIB MOPP (mechlorethamine, vincristine, procarbazine, and prednisone) v ABVD (Adriamycin, bleomycin, vinblastine, and dacarbazine). In 232 previously untreated patients, three cycles of either combination preceded and followed extensive irradiation. The complete remission rate was 80.7% following MOPP and 92.4% following ABVD (P less than .02). The 7-year results indicated that ABVD was superior to MOPP in terms of freedom from progression (80.8% v 62.8%; P less than .002), relapse-free survival (87.7% v 77.2%; P = .06), and overall survival (77.4% v 67.9%; P = .03). Moreover, the comparative iatrogenic morbidity showed that irreversible gonadal dysfunction as well as acute leukemia occurred only in patients subjected to MOPP, while cardiopulmonary studies failed to document significant laboratory differences between the two treatment groups. Present findings indicate that ABVD followed by extensive irradiation represents a valid therapeutic alternative to the widely used alkylating agent-containing regimens plus radiotherapy.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Doença de Hodgkin/tratamento farmacológico , Adulto , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Bleomicina/administração & dosagem , Ensaios Clínicos como Assunto , Terapia Combinada , Dacarbazina/administração & dosagem , Doxorrubicina/administração & dosagem , Feminino , Seguimentos , Doenças dos Genitais Femininos/induzido quimicamente , Doenças dos Genitais Masculinos/induzido quimicamente , Cardiopatias/induzido quimicamente , Doença de Hodgkin/mortalidade , Doença de Hodgkin/radioterapia , Humanos , Pneumopatias/induzido quimicamente , Masculino , Mecloretamina/administração & dosagem , Estadiamento de Neoplasias , Prednisona/administração & dosagem , Procarbazina/administração & dosagem , Distribuição Aleatória , Estatística como Assunto , Vimblastina , Vincristina/administração & dosagem
8.
Clin Infect Dis ; 37(2): 173-9, 2003 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-12856208

RESUMO

Sixty-two strains of Streptococcus pyogenes isolated from 30 asymptomatic school children and 32 children with pharyngitis were characterized to analyze the involvement of 2 fibronectin-binding proteins (F/SfbI and PrtF2/PfbpI) in S. pyogenes colonizing asymptomatic carriers and to determine the possible association between these proteins and the genes associated with macrolide resistance. In this study, we demonstrated that the proportion of S. pyogenes strains carrying the pfbpI gene was significantly higher among asymptomatic carriers (80%) than among children with pharyngitis (53%; P<.05). With regard to the proportion of prtF1-positive strains, no significant differences were found between the 2 groups (70% vs. 69%, for asymptomatic carriers and children with pharyngitis, respectively). Another important finding is the significant association between macrolide resistance and protein F/SfbI (P<.001) in both groups. These results suggest that the presence of the pfbpI gene can be linked to the ability of S. pyogenes to persist in the throat of asymptomatic carriers.


Assuntos
Proteínas de Bactérias/metabolismo , Faringite/microbiologia , Infecções Estreptocócicas/microbiologia , Streptococcus pyogenes/isolamento & purificação , Adesinas Bacterianas/análise , Adesinas Bacterianas/genética , Antígenos de Bactérias , Proteínas de Bactérias/genética , Proteínas de Transporte/metabolismo , Portador Sadio , Criança , Resistência a Medicamentos/genética , Eritromicina/farmacologia , Humanos , Streptococcus pyogenes/efeitos dos fármacos , Streptococcus pyogenes/genética
9.
Int J Radiat Oncol Biol Phys ; 13(6): 853-60, 1987 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-3583856

RESUMO

The experience of the Istituto Nazionale Tumori of Milan on dysgerminoma is presented. Between 1970 and December of 1982, 25 patients were treated with a unique protocol which considered surgery and radiotherapy with different schedules according to the extension of the disease. With this treatment protocol all 13 patients at Stage I were alive and free of disease with a median follow-up of 77 months. Of 12 patients at Stage III (10 retroperitoneal and 2 retroperitoneal and peritoneal) 4 relapsed. The 5-year relapse-free survival of Stage III patients was 61.4% and the overall survival 89.5%. Amenorrhea due to radiation dose absorbed by the contralateral shielded ovary was found in 7.7%. The excellent results in Stage I patients were balanced by the unsatisfactory results in Stage III patients. A more aggressive treatment and the knowledge of other prognostic factors seem necessary.


Assuntos
Disgerminoma/terapia , Neoplasias Ovarianas/terapia , Adolescente , Adulto , Criança , Terapia Combinada , Disgerminoma/radioterapia , Disgerminoma/cirurgia , Feminino , Humanos , Neoplasias Ovarianas/radioterapia , Neoplasias Ovarianas/cirurgia , Prognóstico
10.
Obstet Gynecol ; 60(2): 225-31, 1982 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-7155485

RESUMO

From 1969 to 1977, 420 patients with endometrial carcinoma were observed and treated at the National Tumor Institute of Milan. Total abdominal hysterectomy and bilateral salpingo-oophorectomy were performed in 351. After careful clinical and pathologic review, 262 patients were classified as having stage I disease. Further treatment included post-operative radium therapy to the vaginal vault. There were 247 cases with adenocarcinoma, 10 with adenoacanthoma, and 5 with adenosquamous or clear cell carcinoma. Of 257 cases with adenocarcinoma or adenoacanthoma, 63 were grade 1, 161 grade 2, and 33 grade 3. Of the total series, only 41 cases had disease limited to the mucosal surface. The 5-year actuarial survival was 91.4% and the recurrence-free survival was 93.4%. The case material was evaluated according to the risk factors, and results were 1) premenopausal patients had a better prognosis (100% recurrence-free survival versus 92.8% for postmenopausal women, P = .003); 2) length of the uterine cavity was not a significant prognostic factor; 3) myometrial invasion alone was not prognostic but correlated with grade of tumor; 4) the grade of the tumor was an important determinant of recurrence (grade 1 98% recurrence-free survival, grade 2 95%, grade 3 79%). With the described therapy, vaginal recurrences were absent. The recurrences were distant in 20% and local with or without distant metastases in 80%.


Assuntos
Adenocarcinoma , Carcinoma de Células Escamosas , Neoplasias Uterinas , Adenocarcinoma/mortalidade , Adenocarcinoma/patologia , Adenocarcinoma/terapia , Adulto , Idoso , Carcinoma de Células Escamosas/mortalidade , Carcinoma de Células Escamosas/patologia , Carcinoma de Células Escamosas/terapia , Castração , Feminino , Humanos , Histerectomia , Pessoa de Meia-Idade , Recidiva Local de Neoplasia , Estadiamento de Neoplasias , Prognóstico , Estudos Retrospectivos , Neoplasias Uterinas/mortalidade , Neoplasias Uterinas/patologia , Neoplasias Uterinas/terapia
11.
Obstet Gynecol ; 57(1): 96-8, 1981 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-7454182

RESUMO

Sixty-four patients, 34 with no clinical evidence of disease (NED) and 30 with clinical evidence of disease (ED), were submitted to restaging with peritoneoscopy plus diaphragmatic inspection, peritoneal cytology, and lymphography. Eleven patients (32.2%) in the NED group and 25 (83.3%) in the ED group had positive restaging findings. The 3 diagnostic procedures, in combination, are important in establishing occult disease and therefore in the planning of further treatment.


Assuntos
Neoplasias Ovarianas/patologia , Feminino , Humanos , Estadiamento de Neoplasias
12.
Int J Antimicrob Agents ; 20(6): 451-6, 2002 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-12458140

RESUMO

The in vitro activity of moxifloxacin was compared with that of penicillin G, amoxycillin/clavulanate, cefoxitin, erythromycin, clindamycin and metronidazole against 158 isolates associated with periodontal infections. MIC(50)/MIC(90) values of moxifloxacin were respectively 0.06/0.5 mg/l for Porphyromonas gingivalis (35), for Prevotella spp. (28) and Actinomyces spp. (35), 0.12/0.25 mg/l for Fusobacterium nucleatum (20) and 0.06/0.12 mg/l for Peptostreptococcus spp. (30). The minimum inhibitory concentration (MIC) range of moxifloxacin for Bacteroides forsythus (6) and Campylobacter rectus (4) was 0.06-0.12 mg/l. The minimum bactericidal concentrations were equal to or 2-4 times the MIC values. Moxifloxacin produced a bactericidal effect at 8 h. Our results show that moxifloxacin has good antibacterial activity against periodontal pathogens comparable with that of cefoxitin and amoxycillin/clavulanate, and better than that of clindamycin, metronidazole and penicillin.


Assuntos
Antibacterianos/farmacologia , Anti-Infecciosos/farmacologia , Compostos Aza , Fluoroquinolonas , Bactérias Anaeróbias Gram-Negativas/efeitos dos fármacos , Bactérias Gram-Positivas/efeitos dos fármacos , Doenças Periodontais/microbiologia , Quinolinas , Anaerobiose/efeitos dos fármacos , Humanos , Testes de Sensibilidade Microbiana , Moxifloxacina , Fatores de Tempo
13.
Int J Antimicrob Agents ; 14(2): 151-6, 2000 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10720806

RESUMO

Pseudomonas aeruginosa is important in the field of infectious disease especially with respect to its role in nosocomial infections. Infections with P. aeruginosa may be a problem as the organism has intrinsic resistance to several antibiotics and a capability in acquiring resistance during antibiotic therapy. Fluoroquinolones are sometimes used during antibiotic therapy of P. aeruginosa infections even though resistance to fluoroquinolones may develop. Six strains of P. aeruginosa were studied in an attempt to elucidate the mechanisms of resistance to fluoroquinolones. These included the electrophoresis patterns of the outer membrane proteins (OMPs), random amplified polymorphic DNA (RAPD) and polymerase chain reaction (PCR) analyses. A method is described that improved the clarity of the OMP gels. Resistance in these P. aeruginosa strains could depend not only on DNA-gyrase modifications but also on membranes alterations and on the presence (qualitative and quantitative) of the efflux pump formed by three subunits.


Assuntos
Anti-Infecciosos/farmacologia , Pseudomonas aeruginosa/efeitos dos fármacos , Sequência de Bases , Primers do DNA , Resistência Microbiana a Medicamentos/genética , Eletroforese em Gel de Poliacrilamida , Fluoroquinolonas , Humanos , Testes de Sensibilidade Microbiana , Reação em Cadeia da Polimerase , Infecções por Pseudomonas/tratamento farmacológico , Infecções por Pseudomonas/microbiologia , Pseudomonas aeruginosa/genética
14.
Int J Antimicrob Agents ; 19(2): 111-8, 2002 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11850163

RESUMO

Moxifloxacin is a new oral 8-methoxy-quinolone with a wide spectrum of activity against Gram-negative and anaerobic bacteria, atypical micro-organisms and multi-resistant Gram-positive bacteria. This study was designed to assess the in vitro activity of moxifloxacin against Gram-positive bacteria with different resistance patterns, anaerobes and atypical micro-organisms such as Chlamydia and Mycoplasma. Moxifloxacin had good activity against Streptococcus pneumoniae with all strains inhibited by < or =0.12 mg/l. The minimal inhibitory concentrations (MICs) of moxifloxacin for Streptococcus pyogenes and Streptococcus agalactiae ranged from 0.03 to 0.5 mg/l while those of ciprofloxacin were about two- to four-fold higher (MICs=0.12-1 mg/l). Moxifloxacin was poorly active against enterococci but its activity against Clostridium and Bacteroides spp. was in the same range as that of metronidazole and superior to that of clindamycin. Moxifloxacin was substantially more active than both ciprofloxacin and sparfloxacin against Chlamydia.


Assuntos
Anti-Infecciosos/farmacologia , Compostos Aza , Bactérias/efeitos dos fármacos , Fluoroquinolonas , Quinolinas , Aerobiose/efeitos dos fármacos , Anaerobiose/efeitos dos fármacos , Antibacterianos/farmacologia , Ceftriaxona/farmacologia , Cefalosporinas/farmacologia , Ciprofloxacina/farmacologia , Clindamicina/farmacologia , Clostridium/efeitos dos fármacos , Farmacorresistência Bacteriana Múltipla , Eritromicina/farmacologia , Imipenem/farmacologia , Testes de Sensibilidade Microbiana , Moxifloxacina , Mycoplasma/efeitos dos fármacos , Streptococcus/efeitos dos fármacos , Teicoplanina/farmacologia , Tienamicinas/farmacologia , Vancomicina/farmacologia
15.
Acad Radiol ; 2(9): 741-7, 1995 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-9419634

RESUMO

RATIONALE AND OBJECTIVES: Magnetic resonance (MR) imaging has been suggested as a method to monitor interstitial laser phototherapy (ILP) in deep tissues. Unfortunately, a reliable relation between temperature and MR parameters has not yet been demonstrated. In this study, we examined whether such a relation exists and whether MR imaging can measure absolute temperature or temperature changes. METHODS: We evaluated, in the range of 21 degrees C to 80 degrees C, the temperature dependence of the MR imaging signal and T1 in samples of liver, water, CuSO4, and oil. Spin-echo and fast low-angle shot (FLASH) sequences were used. RESULTS: The MR imaging signal of liver, CuSO4, and water continuously decreased when the temperature was increased from 21 degrees C to 80 degrees C. By contrast, the MR imaging signal of the oil increased with increasing temperature up to 40-50 degrees C and then decreased at higher temperatures. We observed a reliable linear relation only between T1 and temperature in a range' of 30-60 degrees C for oil and CuSO4. CONCLUSION: MR imaging has the potential to measure thermal variations with an uncertainty of approximately +/- 10 degrees C. However, the use of MR imaging to monitor the real-time thermal effect induced in biologic tissues during laser irradiation requires further investigation before it can be applied clinically.


Assuntos
Terapia a Laser , Imageamento por Ressonância Magnética , Fototerapia , Animais , Bovinos , Sulfato de Cobre , Técnicas In Vitro , Fígado , Monitorização Fisiológica , Óleos , Temperatura , Água
16.
Eur J Radiol ; 12(2): 81-90, 1991.
Artigo em Inglês | MEDLINE | ID: mdl-2037005

RESUMO

Seventy-four consecutive previously untreated patients with Hodgkin's disease (HD) and non-Hodgkin lymphomas (NHL) were evaluated with chest, abdominal and pelvic magnetic resonance (MRI) for initial staging. All patients underwent routine radiological staging procedures which included chest radiographs and lymphography (LAG). These studies were followed in most of cases by laparoscopy, during which biopsies of the liver and the spleen were taken, and bone marrow aspiration and histology. A correlation of the results of MRI with both other imaging studies and histopathologic diagnoses was performed, and discordant cases were assessed to determine the impact on clinical staging. Additional evidence of disease involvement was provided mainly in the chest, where MRI demonstrated the presence of unsuspected disease in 21% of involved patients (9 of 42). Retroperitoneal lymph nodes were correctly assessed in 97% of cases if MRI was compared with LAG. Extranodal abdominal disease was identified both in the spleen (14%) and in the liver (1%). Bone marrow abnormalities were detected in 19% of patients (14 of 74). MRI findings influenced the staging of HD and NHL patients in 11 of 74 cases (15%).


Assuntos
Doença de Hodgkin/patologia , Linfonodos/patologia , Linfoma não Hodgkin/patologia , Abdome , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Medula Óssea , Feminino , Doença de Hodgkin/diagnóstico , Humanos , Metástase Linfática , Linfoma não Hodgkin/diagnóstico , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias/métodos , Estudos Retrospectivos , Tórax
17.
Eur J Radiol ; 8(4): 226-30, 1988 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-3234399

RESUMO

Nine patients underwent magnetic resonance imaging (MRI) as part of the diagnostic evaluation for cardiac masses; eight of them had been preliminarily studied by 2D-echocardiography (US). MRI did not add to the US diagnostic information in patients affected by intracavitary masses. It represented the definitive diagnostic modality in two patients with intramural pathology: one with ventricular rhabdomyoma, the second with an echinococcyal cyst located within the left atrial wall. The complementary role of MRI to US in cardiac masses is discussed.


Assuntos
Ecocardiografia , Cardiopatias/diagnóstico , Imageamento por Ressonância Magnética , Adolescente , Adulto , Criança , Pré-Escolar , Ecocardiografia/economia , Feminino , Neoplasias Cardíacas/diagnóstico , Humanos , Imageamento por Ressonância Magnética/normas , Masculino , Pessoa de Meia-Idade , Fatores de Tempo
18.
Eur J Radiol ; 15(2): 171-4, 1992 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-1425758

RESUMO

After the incidental observation of the high signal intensity of the upper GI tract in a nourished baby, we tested eight baby milks; five different fresh commercial milks, one sweetened and condensed and two lyophilized milks in order to compare their ability to contrast MR images. The images were obtained with a 1.5 T magnet whereas the "in vitro" water proton relaxation time (T1 and T2) measurements were carried out at 0.5 T. After having selected the most effective lyophilized product, that was prepared according to the manufacturer's instructions, a group of 23 adult patients, 17 males and 6 females, with a mean age of 55.8 years (range 37 to 71 years) were examined. Thirteen patients had gastric cancer and ten patients had rectal or rectosigmoid junction tumors. The most effective imaging sequence was a spin-echo T1.w. After oral intake of milk a good contrast of the stomach, with sufficient distribution in the duodenum and the very proximal bowel, was achieved in all 13 patients with gastric cancer, as was a good depiction of the rectum and the recto-sigmoid junction after enema achieved in the 10 patients with rectal cancers. Disadvantages of lyophilized milk as a contrast agent are due to partial intestinal absorption, inhomogeneous distribution and irregular intestinal passage, whereas a clear advantage of lyophilized milk as a contrast agent is its good acceptance and palatable, inexpensive and non invasive properties. Because of these limitations lyophilized milk cannot be considered a real oral contrast medium but it can enhance MR imaging of the upper abdomen, and mainly of the lower GI tract in infants and adults.


Assuntos
Meios de Contraste , Sistema Digestório/patologia , Neoplasias Gastrointestinais/diagnóstico , Imageamento por Ressonância Magnética , Leite , Adulto , Idoso , Animais , Feminino , Humanos , Aumento da Imagem/métodos , Recém-Nascido , Recém-Nascido Prematuro , Masculino , Pessoa de Meia-Idade
19.
J Exp Clin Cancer Res ; 21(3 Suppl): 125-30, 2002 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12585666

RESUMO

Because of the higher risk of developing breast cancer and the early onset of the disease in women proved or suspected to be carriers of a breast cancer susceptibility gene, a dedicated screening should be offered as a less invasive approach with respect to the otherwise suggested prophylactic mastectomy. This should be optimized in order to overcome the limitations of conventional breast imaging with the application of new technologies such as Breast Magnetic Resonance Imaging (BMRI). A diagnostic protocol for routine control in patients with high risk for developing breast cancer has been prepared. Within a 7 months period, 23 patients suspected or proved to carry a breast cancer susceptibility gene underwent BMRI. Four breast cancers were identified with BMRI. In these cases mammography was negative because of the density of the parenchyma or for its fibroglandular pattern. US was negative in two cases, not specific for malignancy in one case and considered as only possibly malignant but with biopsy recommendation on the basis of MR findings in the last one. Clinic analysis was positive for mass in two cases. The accuracy of BMRI is known to be higher than that of conventional imaging in the study of breast parenchyma. High spatial resolution and no breast density influence can give more detailed information about smaller lesions and the right extent of the disease.


Assuntos
Neoplasias da Mama/diagnóstico , Imageamento por Ressonância Magnética , Programas de Rastreamento , Adulto , Neoplasias da Mama/genética , Neoplasias da Mama/patologia , Feminino , Genes BRCA1 , Genes BRCA2 , Predisposição Genética para Doença , Humanos , Mamografia , Pessoa de Meia-Idade , Mutação , Técnica de Subtração , Ultrassonografia Mamária
20.
J Exp Clin Cancer Res ; 21(3 Suppl): 115-24, 2002 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12585665

RESUMO

This report presents the preliminary results of the first phase (21 months) of a multi-centre, non-randomised, prospective study, aimed at evaluating the effectiveness of contrast-enhanced magnetic resonance imaging (MRI), X-ray mammography (XM) and ultrasound (US) in early diagnosis of breast cancer (BC) in subjects at high genetic risk. This Italian national trial (coordinated by the Istituto Superiore di Sanità, Rome) so far recruited 105 women (mean age 46.0 years; median age 51.0; age range 25-77 years), who were either proven BRCA1 or BRCA2 mutation carriers or had a 1 in 2 probability of being carriers (40/105 with a previous personal history of BC). Eight cases of breast carcinomas were detected in the trial (mean age 55.3 years, median age 52.5; age range 35-70 years; five with previous personal history of BC). All trial-detected BC cases (8/8) were identified by MRI, while XM and US correctly classified only one. MRI had one false positive case, XM and US none. Seven "MRI-only" detected cancers (4 invasive, 3 in situ) occurred in both pre- (n = 2) and post-menopausal (n = 5) women. With respect to the current XM screening programmes addressed to women in the age range 50-69 years, the global incidence of BC in the trial (7.6%) was over ten-fold higher. The cost per "MRI-only" detected cancer in this particular category of subjects at high genetic risk was substantially lower than that of an XM-detected cancer in the general women population. These preliminary results confirmed that MRI is a very useful tool to screen subjects at high genetic risk for breast carcinoma, not only in pre-, but also in post-menopausal age, with a low probability of false positive cases.


Assuntos
Neoplasias da Mama/diagnóstico , Imageamento por Ressonância Magnética , Programas de Rastreamento , Adulto , Neoplasias da Mama/genética , Neoplasias da Mama/patologia , Reações Falso-Positivas , Feminino , Gadolínio , Genes BRCA1 , Genes BRCA2 , Predisposição Genética para Doença , Humanos , Mamografia , Programas de Rastreamento/economia , Pessoa de Meia-Idade , Mutação , Estudos Prospectivos , Intensificação de Imagem Radiográfica , Ultrassonografia Mamária
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA